Reviv3 Procare Company
RVIV · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $27,499 | $23,521 | $2,336 |
| % Growth | -100% | 16.9% | 906.8% | – |
| Cost of Goods Sold | $0 | $7,305 | $5,810 | $829 |
| Gross Profit | $18,642 | $20,194 | $17,711 | $1,508 |
| % Margin | – | 73.4% | 75.3% | 64.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $652 | $0 | $4,051 | $520 |
| SG&A Expenses | $12,104 | $0 | $15,727 | $1,719 |
| Sales & Mktg Exp. | $11,452 | $0 | $11,675 | $1,199 |
| Other Operating Expenses | $0 | $18,691 | $0 | $0 |
| Operating Expenses | $12,104 | $18,691 | $15,727 | $1,719 |
| Operating Income | $3,669 | $1,503 | $1,984 | -$211 |
| % Margin | – | 5.5% | 8.4% | -9% |
| Other Income/Exp. Net | $0 | $0 | $71 | $29 |
| Pre-Tax Income | $0 | $0 | $2,055 | -$183 |
| Tax Expense | $0 | $0 | $231 | -$29 |
| Net Income | $0 | $0 | $1,825 | -$154 |
| % Margin | – | 0% | 7.8% | -6.6% |
| EPS | 0 | 0 | 0.32 | -0.074 |
| % Growth | – | -100% | 534.8% | – |
| EPS Diluted | 0 | 0 | 0.1 | -0.074 |
| Weighted Avg Shares Out | 0 | 6,157 | 5,645 | 2,097 |
| Weighted Avg Shares Out Dil | 0 | 13,373 | 17,869 | 2,097 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $6 | $0 |
| Interest Expense | $0 | $0 | $3 | $7 |
| Depreciation & Amortization | $148 | $0 | $95 | $8 |
| EBITDA | $3,817 | $1,503 | $2,149 | -$168 |
| % Margin | – | 5.5% | 9.1% | -7.2% |